The four-day extension of mean disease endpoint for the HuMab 37 L-63 treated group did not reach statistical significance.
← all excerpts
Identification of human monoclonal antibodies specific for human SOD1 recognizing distinct epitopes and forms of SOD1.
2
—
—
The sentences
The IP delivery of HuMab 37 L-63 , gave an encouraging trend toward extended survival that was not statistically significant.